<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2(4)</volume><submitter>Singh SM</submitter><funding>Boston Scientific Corporation</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients' psychological health.&lt;h4>Objective&lt;/h4>We sought to improve understanding of the level of anxiety and depression as well as device acceptance among inherited channelopathy patients with an ICD.&lt;h4>Methods&lt;/h4>Eligible patients seen at Johns Hopkins Hospital were sent a survey, which included the Hospital Anxiety and Depression Scale (HADS), Cardiac Anxiety Questionnaire (CAQ), and the Florida Patient Acceptance Survey (FPAS). Student &lt;i>t&lt;/i> tests and χ&lt;sup>2&lt;/sup> tests were used to identify associations with abnormal anxiety and depression scores.&lt;h4>Results&lt;/h4>A</pubmed_abstract><journal>Heart rhythm O2</journal><pagination>388-393</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8369306</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators.</pubmed_title><pmcid>PMC8369306</pmcid><pubmed_authors>Singh SM</pubmed_authors><pubmed_authors>Murray B</pubmed_authors><pubmed_authors>Tichnell C</pubmed_authors><pubmed_authors>McClellan R</pubmed_authors><pubmed_authors>James CA</pubmed_authors><pubmed_authors>Barth AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators.</name><description>&lt;h4>Background&lt;/h4>Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients' psychological health.&lt;h4>Objective&lt;/h4>We sought to improve understanding of the level of anxiety and depression as well as device acceptance among inherited channelopathy patients with an ICD.&lt;h4>Methods&lt;/h4>Eligible patients seen at Johns Hopkins Hospital were sent a survey, which included the Hospital Anxiety and Depression Scale (HADS), Cardiac Anxiety Questionnaire (CAQ), and the Florida Patient Acceptance Survey (FPAS). Student &lt;i>t&lt;/i> tests and χ&lt;sup>2&lt;/sup> tests were used to identify associations with abnormal anxiety and depression scores.&lt;h4>Results&lt;/h4>A</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-19T18:12:28.279Z</modification><creation>2025-04-19T18:12:28.279Z</creation></dates><accession>S-EPMC8369306</accession><cross_references><pubmed>34430944</pubmed><doi>10.1016/j.hroo.2021.06.001</doi></cross_references></HashMap>